Evidence map›Paper›PMID 37958251›Full record

ArticleDiagnostics (Basel, Switzerland)2023

The Detection of Colorectal Cancer through Machine Learning-Based Breath Sensor Analysis.

Inese Poļaka, Linda Mežmale, Linda Anarkulova, Elīna Kononova, Ilona Vilkoite, Viktors Veliks, Anna Marija Ļeščinska, Ilmārs Stonāns, Andrejs Pčolkins, Ivars Tolmanis and 6 more

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Inese PoļakaInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.ORCID 0000-0002-9892-7765
Linda MežmaleInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.ORCID 0000-0001-7765-852X
Linda AnarkulovaInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.
Elīna KononovaInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.
Ilona VilkoiteHealth Centre 4, LV-1012 Riga, Latvia.
Viktors VeliksInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.ORCID 0000-0002-4380-9534
Anna Marija ĻeščinskaInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.
Ilmārs StonānsInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.
Andrejs PčolkinsInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.
Ivars TolmanisFaculty of Medicine, Riga Stradins University, LV-1007 Riga, Latvia.
Gidi ShaniLaboratory for Nanomaterial-Based Devices, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
Hossam HaickLaboratory for Nanomaterial-Based Devices, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
Jan MitrovicsJLM Innovation GmbH, D-72070 Tübingen, Germany.
Johannes GlöcklerInstitute of Analytical and Bioanalytical Chemistry, Ulm University, 89081 Ulm, Germany.ORCID 0000-0003-1941-2665
Boris MizaikoffInstitute of Analytical and Bioanalytical Chemistry, Ulm University, 89081 Ulm, Germany.
Mārcis LejaInstitute of Clinical and Preventive Medicine, University of Latvia, LV-1586 Riga, Latvia.ORCID 0000-0002-0319-8855

Funding

European Regional Development Fund Nr. 1.1.1.1/20/A/035
6 · The paper itself

Abstract

Colorectal cancer (CRC) is the third most common malignancy and the second most common cause of cancer-related deaths worldwide. While CRC screening is already part of organized programs in many countries, there remains a need for improved screening tools. In recent years, a potential approach for cancer diagnosis has emerged via the analysis of volatile organic compounds (VOCs) using sensor technologies. The main goal of this study was to demonstrate and evaluate the diagnostic potential of a table-top breath analyzer for detecting CRC. Breath sampling was conducted and CRC vs. non-cancer groups (105 patients with CRC, 186 non-cancer subjects) were included in analysis. The obtained data were analyzed using supervised machine learning methods (i.e., Random Forest, C4.5, Artificial Neural Network, and Naïve Bayes). Superior accuracy was achieved using Random Forest and Evolutionary Search for Features (79.3%, sensitivity 53.3%, specificity 93.0%, AUC ROC 0.734), and Artificial Neural Networks and Greedy Search for Features (78.2%, sensitivity 43.3%, specificity 96.5%, AUC ROC 0.735). Our results confirm the potential of the developed breath analyzer as a promising tool for identifying and categorizing CRC within a point-of-care clinical context. The combination of MOX sensors provided promising results in distinguishing healthy vs. diseased breath samples. Its capacity for rapid, non-invasive, and targeted CRC detection suggests encouraging prospects for future clinical screening applications.

Indexed as

breath analyzercolorectal cancermachine learningscreeningsensorsvolatile organic compounds

Identifiers

PMID37958251
PMCPMC10648537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.